- Latest news▼
-
12:16, April 19 Scientists grow human mini-lungs in lab
-
10:23, April 19 JAMA Oncology: Urine test can help rule out high-grade prostate cancer with almost 100% accuracy, study shows
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
-
08:38, April 17 Why do kids usually recover from COVID-19 more easily than adults?
-
14:37, April 16 Daily Mail: intermittent fasting is not suitable for children and women before their periods
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
All materials
Oxford COVID-19 vaccine may be ready for Christmas
A coronavirus vaccine being developed by the University of Oxford may be ready for Christmas. However, by this time, most likely, it will be possible to produce no more than 4 million doses, so only key workers will be able to receive the vaccine.
According to The Daily Mail, the joint project of the pharmaceutical company AstraZeneca and the University of Oxford is currently considered the most promising COVID-19 vaccine.
The third stage of the vaccine study is already being completed, after which it will be able to officially register it.
Pfizer is expected to produce 10 million doses of its vaccine by January, which is also completing its third phase of trials. Numerous health-care workers and the elderly are expected to receive the vaccine first, as they are at the risk group.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- WHO: Nigeria pioneers revolutionary meningitis vaccine 1185
- One-third of women experience menstruation-related migraines, most often during premenopause - study 1176
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 1046
- Food and Environmental Virology: tea contributes to effective coronavirus control 1037
- Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk 1010
- 305 cases of measles recorded in Armenia so far in 2024 1002
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 970
- Diabetes Care: evening physical activity is good for the heart 926
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 821
- First Armenian-German Conference entitled “Heart Failure Spring School” 600
- Why do kids usually recover from COVID-19 more easily than adults? 491
- Obesity: exercising before breakfast helps you lose weight faster 491
- The Conversation: childhood trauma can cause pathological hoarding 486
- Daily Mail: Elderly woman in China gets infected with brain-eating amoeba 471
- Daily Mail: Satiating food reduces cravings for sweets, nutritionist says 465
- Find us on Facebook
- Poll